UCB
This role involves contributing to cutting-edge work in combinatorial immunotherapy and cell depletion to shape safe and effective medicines for immune-mediated diseases. The position offers opportunities at various career levels, from scientific contribution to strategic leadership, within a growing team focused on next-generation immunology. You will influence emerging development programs by providing scientific insight and sound benefit-risk decisions to improve patient outcomes.
Headquarters
Brussels, Brussels, Belgium
Company Size
5001-10000 employees
Founded
1928
UCB a global biopharmaceutical leader focuses on creating valuable solutions that improve the lives of people living with neurological and autoimmune conditions
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for UCB.
UCB didn’t post a salary, so this is our estimate from similar listings.
12% below the average for this role
Director, Immunology Scientific Innovation
AstraZeneca
Associate Director Clinical Scientist Immunology Cell Therapy
AstraZeneca
Vice President, Therapeutics Immunology
Moderna
Senior Scientist, Biology-Discovery
Merck & Co., Inc.
T-Cell Engineering Scientist
Mayo Clinic
T-Cell Engineering Scientist
Mayo Clinic